研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2025 年 · SMMR
Statistical Methods in Medical Research,2025 年发表的 136 篇,新的在前。点标题看作者和摘要。回到 2025 年
- Robust Emax model fitting: Addressing nonignorable missing binary outcome in dose–response analysis · SMMR · 2025-12-29 · 在第 1 页
- Dynamic prediction of death risk given a renewal hospitalization process · SMMR · 2025-12-19 · 在第 1 页
- Two stage least squares with time-varying instruments: An application to an evaluation of treatment intensification for type-2 diabetes · SMMR · 2025-12-15 · 在第 1 页
- Joint mixed-effects models for causal inference in clustered network-based observational studies · SMMR · 2025-12-15 · 在第 1 页
- The use of the EM algorithm for regularization problems in high-dimensional linear mixed-effects models · SMMR · 2025-12-09 · 在第 2 页
- Dynamic prediction by landmarking with data from cohort subsampling designs · SMMR · 2025-12-08 · 在第 2 页
- Diagnostic accuracy analysis for multiple raters using probit hierarchical model for ordinal ratings · SMMR · 2025-12-08 · 在第 2 页
- Joint time-to-event partial order continual reassessment method and Joint time-to-event Bayesian logistic regression model: Statistical designs for dual agent phase I/II dose finding studies with late-onset toxicity and activity outcomes · SMMR · 2025-12-05 · 在第 2 页
- Augmented binary method for basket trials (ABBA) · SMMR · 2025-12-05 · 在第 2 页
- Penalized estimation of general frailty Poisson models for recurrent count events · SMMR · 2025-12-02 · 在第 3 页
- Estimation of the short-term and long-term hazard ratios for interval-censored and truncated data · SMMR · 2025-12-02 · 在第 3 页
- Adaptive sample size re-estimation designs for a two-stage randomized trial with binary outcome · SMMR · 2025-11-27 · 在第 3 页
- Informative simultaneous confidence intervals for graphical test procedures · SMMR · 2025-11-14 · 在第 4 页
- A jackknife approach to estimate the prediction uncertainty from binary classifiers under right-censoring · SMMR · 2025-11-14 · 在第 4 页
- Latent classification of time-dependent transition rates in longitudinal binary outcome data · SMMR · 2025-11-13 · 在第 4 页
- Using inverse probability of censoring weighting to estimate hypothetical estimands in clinical trials: Should we implement stabilisation, and if so how? · SMMR · 2025-10-31 · 在第 5 页
- Comparative study of Bayesian and frequentist methods for epidemic forecasting: Insights from simulated and historical data · SMMR · 2025-10-25 · 在第 5 页
- Two-stage Bayesian network meta-analysis of individualized treatment rules for multiple treatments with siloed data · SMMR · 2025-10-24 · 在第 5 页
- Center-specific causal inference with multicenter trials—Interpreting trial evidence in the context of each participating center · SMMR · 2025-10-21 · 在第 5 页
- Modeling the effect of longitudinal markers on left-truncated time-to-event outcomes in twin studies · SMMR · 2025-10-14 · 在第 6 页
- Meta-analysis with a single study · SMMR · 2025-10-09 · 在第 6 页
- Assessing spillover effects: Handling missing outcomes in network-based studies · SMMR · 2025-10-07 · 在第 7 页
- Implementing response-adaptive randomisation in stratified rare-disease trials: Design challenges and practical solutions · SMMR · 2025-10-06 · 在第 7 页
- On identification and estimation for sufficient cause interaction through a quasi-instrumental variable · SMMR · 2025-09-30 · 在第 7 页
- Investigations of sharp bounds for causal effects under selection bias · SMMR · 2025-09-30 · 在第 8 页
- Augmented two-stage estimation for treatment switching in oncology trials: Leveraging external data for improved precision · SMMR · 2025-09-30 · 在第 8 页
- Bayesian clustering prior with overlapping indices for effective use of multisource external data · SMMR · 2025-09-15 · 在第 9 页
- A robust Bayesian dose optimization design with backfill and randomization for phase I/II clinical trials · SMMR · 2025-09-05 · 在第 9 页
- A comparison of semi-parametric statistical modeling approaches to dynamic classification of irregularly and sparsely sampled curves · SMMR · 2025-09-04 · 在第 9 页
- Implementing response-adaptive designs when responses are missing: Impute or ignore? · SMMR · 2025-08-29 · 在第 9 页
- Exact power and sample size in clinical trials with two co-primary binary endpoints · SMMR · 2025-08-29 · 在第 9 页
- A Bayesian approach towards the identification of latent subgroups · SMMR · 2025-08-29 · 在第 9 页
- Imputation of incomplete ordinal and nominal data by predictive mean matching · SMMR · 2025-08-17 · 在第 10 页
- Selecting the optimal longitudinal cluster randomized design with a continuous outcome: Parallel-arm, crossover, or stepped-wedge · SMMR · 2025-08-11 · 在第 11 页
- On prior smoothing with discrete spatial data in the context of disease mapping · SMMR · 2025-08-08 · 在第 11 页
- A note on response-adaptive randomization from a Bayesian prediction viewpoint · SMMR · 2025-08-06 · 在第 11 页
- Efficient randomized adaptive designs for multi-arm clinical trials · SMMR · 2025-07-30 · 在第 12 页
- To what extent is response-adaptive randomization used in clinical trials? A systematic review using Cortellis Regulatory Intelligence database · SMMR · 2025-07-24 · 在第 12 页
- Optimal treatment regimes in the presence of a cure fraction · SMMR · 2025-07-17 · 在第 13 页
- Group sequential designs for survival outcomes with adaptive randomization · SMMR · 2025-07-17 · 在第 13 页
- Design of egocentric network-based studies to estimate causal effects under interference · SMMR · 2025-07-17 · 在第 13 页
- Semiparametric regression analysis of interval-censored failure time data with a cure subgroup and nonignorable missing covariates · SMMR · 2025-07-14 · 在第 14 页
- Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designs · SMMR · 2025-07-13 · 在第 14 页
- Inference procedures in sequential trial emulation with survival outcomes: Comparing confidence intervals based on the sandwich variance estimator, bootstrap and jackknife · SMMR · 2025-07-09 · 在第 14 页
- Health utility adjusted survival: A composite endpoint for clinical trial designs · SMMR · 2025-07-09 · 在第 14 页
- Estimation of receiver operating characteristic curve when case and control require different transformations for normality · SMMR · 2025-07-09 · 在第 14 页
- Population-adjusted unanchored indirect comparisons of cancer therapies with borrowing of pan-tumor information · SMMR · 2025-07-04 · 在第 14 页
- Closed-form confidence intervals for saved time using summary statistics in Alzheimer’s disease studies · SMMR · 2025-07-04 · 在第 15 页
- Two-stage subsampling variable selection for sparse high-dimensional generalized linear models · SMMR · 2025-07-02 · 在第 15 页
- Group sequential analysis of marked point processes: Plasma donation trials · SMMR · 2025-07-02 · 在第 15 页
- Two-stage targeted minimum-loss based estimation for non-negative two-part outcomes · SMMR · 2025-06-26 · 在第 15 页
- Strategies to boost statistical efficiency in randomized oncology trials with primary time-to-event endpoints · SMMR · 2025-06-23 · 在第 15 页
- Multiple imputation for systematically missing effect modifiers in individual participant data meta-analysis · SMMR · 2025-06-20 · 在第 15 页
- Spatiotemporal effects on dengue incidence based on a large cluster randomized study · SMMR · 2025-06-19 · 在第 16 页
- Incorporation of missing indicator with multiple imputation in propensity score analysis with partially observed covariates: A simulation study · SMMR · 2025-06-19 · 在第 16 页
- Fast leave-one-cluster-out cross-validation using clustered network information criterion · SMMR · 2025-06-19 · 在第 16 页
- Design optimization of longitudinal studies using metaheuristics: Application to lithium pharmacokinetics · SMMR · 2025-06-19 · 在第 16 页
- Response adaptive randomisation in clinical trials: Current practice, gaps and future directions · SMMR · 2025-06-18 · 在第 16 页
- Permutation tests for detecting treatment effect heterogeneity in cluster randomized trials · SMMR · 2025-06-17 · 在第 16 页
- Multiply robust causal inference in the presence of an error-prone treatment · SMMR · 2025-06-12 · 在第 16 页
- Flexible regression methods for estimating optimal individualized treatment regimes with scalar and functional covariates · SMMR · 2025-06-09 · 在第 16 页
- Assessing accuracy for multi-class classification when subclasses are involved · SMMR · 2025-06-05 · 在第 17 页
- Paired count regressions for modeling the number of doctor consultations and non-prescribed drugs intake · SMMR · 2025-05-29 · 在第 17 页
- Influence function-based empirical likelihood for area under the receiver operating characteristic curve in presence of covariates · SMMR · 2025-05-29 · 在第 17 页
- Bayesian inference for nonlinear mixed-effects location scale and interval-censoring cure-survival models: An application to pregnancy miscarriage · SMMR · 2025-05-29 · 在第 18 页
- Alternatives to default shrinkage methods can improve prediction accuracy, calibration, and coverage: A methods comparison study · SMMR · 2025-05-29 · 在第 18 页
- A shared frailty regression model for clustered survival data · SMMR · 2025-05-29 · 在第 18 页
- Quantification of the influence of risk factors with application to cardiovascular diseases in subjects with type 1 diabetes · SMMR · 2025-05-21 · 在第 18 页
- A model-free phase I/II dose optimization design for immunotherapy trials · SMMR · 2025-05-15 · 在第 19 页
- Reproducible feature selection in heterogeneous multicenter datasets via sign-consistency criteria · SMMR · 2025-05-14 · 在第 19 页
- Rank-based estimators of global treatment effects for cluster randomized trials with multiple endpoints on different scales · SMMR · 2025-05-14 · 在第 19 页
- Permutation-based global rank test with adaptive weights for multiple primary endpoints · SMMR · 2025-05-14 · 在第 19 页
- Penalized estimation for varying coefficient additive hazards models · SMMR · 2025-05-14 · 在第 19 页
- Evaluating the sample size requirements of tree-based ensemble machine learning techniques for clinical risk prediction · SMMR · 2025-05-14 · 在第 19 页
- Analysis of recurrent events in cluster randomised trials: The PLEASANT trial case study · SMMR · 2025-05-14 · 在第 19 页
- A family of Bayesian prognostic and predictive covariate-adjusted response-adaptive randomization designs · SMMR · 2025-05-14 · 在第 19 页
- Novel empirical likelihood method for the cumulative hazard ratio under stratified Cox models · SMMR · 2025-05-13 · 在第 19 页
- Partial areas under the curve of the cumulative distribution function as a new composite estimand for randomized clinical trials · SMMR · 2025-04-28 · 在第 20 页
- On flexible inverse probability of treatment and intensity weighting: Informative censoring, variable selection, and weight trimming · SMMR · 2025-04-28 · 在第 20 页
- Estimation of global average treatment effect in National Heart, Lung, and Blood Institute (NHLBI) Growth and Health Study · SMMR · 2025-04-13 · 在第 21 页
- Covariate selection for optimizing balance with an innovative adaptive randomization approach · SMMR · 2025-04-13 · 在第 21 页
- Sequential design for paired ordinal categorical outcome · SMMR · 2025-03-31 · 在第 22 页
- Optimising error rates in programmes of pilot and definitive trials using Bayesian statistical decision theory · SMMR · 2025-03-31 · 在第 22 页
- On the achievability of efficiency bounds for covariate-adjusted response-adaptive randomization · SMMR · 2025-03-31 · 在第 22 页
- Methodology for supervised optimization of the construction of physician shared-patient networks · SMMR · 2025-03-31 · 在第 22 页
- G-formula with multiple imputation for causal inference with incomplete data · SMMR · 2025-03-31 · 在第 22 页
- Estimand-based inference in the presence of long-term survivors · SMMR · 2025-03-31 · 在第 22 页
- Dose selection criteria to identify the optimal dose based on ranked efficacy-toxicity outcomes without reliance on clinical utilities · SMMR · 2025-03-31 · 在第 22 页
- Biomarker-driven optimal designs for patient enrollment restriction · SMMR · 2025-03-31 · 在第 22 页
- A computationally efficient approach to false discovery rate control and power maximisation via randomisation and mirror statistic · SMMR · 2025-03-31 · 在第 22 页
- A Weibull mixture cure frailty model for high-dimensional covariates · SMMR · 2025-03-31 · 在第 22 页
- Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint · SMMR · 2025-03-25 · 在第 22 页
- Causal mediation analysis for time-to-event mediator and outcome in the presence of left truncation · SMMR · 2025-03-24 · 在第 22 页
- Boosting distributional copula regression for bivariate binary, discrete and mixed responses · SMMR · 2025-03-21 · 在第 23 页
- The joint quantile regression modeling of mixed ordinal and continuous responses with its application to an obesity risk data · SMMR · 2025-03-20 · 在第 23 页
- Simultaneous variable selection and estimation for a partially linear Cox model · SMMR · 2025-03-20 · 在第 23 页
- Semi-parametric testing for ordinal treatment effects in time-to-event data via dynamic Dirichlet process mixtures of the inverse-Gaussian distribution · SMMR · 2025-03-20 · 在第 23 页
- Sample size determinations in four-level longitudinal cluster randomized trials with random slope · SMMR · 2025-03-20 · 在第 23 页
- On estimation of overall treatment effects in multiregional clinical trials under a discrete random effects model · SMMR · 2025-03-20 · 在第 23 页
- Interval estimation for the Youden index of a continuous diagnostic test with verification biased data · SMMR · 2025-03-20 · 在第 23 页
- How to add baskets to an ongoing basket trial with information borrowing · SMMR · 2025-03-20 · 在第 23 页
- Effect estimation in the presence of a misclassified binary mediator · SMMR · 2025-03-20 · 在第 23 页
- Covariate-adjusted inference for doubly adaptive biased coin design · SMMR · 2025-03-20 · 在第 23 页
- Additive hazard causal model with a binary instrumental variable · SMMR · 2025-03-20 · 在第 23 页
- A connection between covariate adjustment and stratified randomization in randomized clinical trials · SMMR · 2025-03-20 · 在第 23 页
- An iterative matrix uncertainty selector for high-dimensional generalized linear models with measurement errors · SMMR · 2025-03-19 · 在第 23 页
- Relationship between collider bias and interactions on the log-additive scale · SMMR · 2025-03-02 · 在第 24 页
- A new cure model accounting for longitudinal data and flexible patterns of hazard ratios over time · SMMR · 2025-02-28 · 在第 24 页
- Outcome adaptive propensity score methods for handling censoring and high-dimensionality: Application to insurance claims · SMMR · 2025-02-27 · 在第 24 页
- Generalized framework for identifying meaningful heterogenous treatment effects in observational studies: A parametric data-adaptive G-computation approach · SMMR · 2025-02-24 · 在第 24 页
- Extension of Fisher’s least significant difference method to multi-armed group-sequential response-adaptive designs · SMMR · 2025-02-24 · 在第 24 页
- The relative efficiency of staircase and stepped wedge cluster randomised trial designs · SMMR · 2025-02-16 · 在第 25 页
- Using Bayesian evidence synthesis to quantify uncertainty in population trends in smoking behaviour · SMMR · 2025-02-12 · 在第 25 页
- Robust propensity score estimation via loss function calibration · SMMR · 2025-02-12 · 在第 25 页
- Long-term Dagum-power variance function frailty regression model: Application in health studies · SMMR · 2025-02-12 · 在第 25 页
- Jointly assessing multiple endpoints in pilot and feasibility studies · SMMR · 2025-02-12 · 在第 25 页
- Bayesian mixture models for phylogenetic source attribution from consensus sequences and time since infection estimates · SMMR · 2025-02-12 · 在第 25 页
- Statistical considerations for evaluating treatment effect under various non-proportional hazard scenarios · SMMR · 2025-02-11 · 在第 25 页
- Modeling the ratio of correlated biomarkers using copula regression · SMMR · 2025-02-11 · 在第 25 页
- Hierarchical Bayesian bivariate spatial modeling of small area proportions with application to health survey data · SMMR · 2025-02-11 · 在第 25 页
- Causal survival embeddings: Non-parametric counterfactual inference under right-censoring · SMMR · 2025-02-11 · 在第 25 页
- Distribution-free control charts for mixed-type data based on rank of interpoint distances · SMMR · 2025-02-10 · 在第 26 页
- Modelling extensions for multi-location studies in environmental epidemiology · SMMR · 2025-02-05 · 在第 26 页
- Weighting methods for truncation by death in cluster-randomized trials · SMMR · 2025-01-31 · 在第 27 页
- Multivariate contaminated normal linear mixed models applied to Alzheimer’s disease study with censored and missing data · SMMR · 2025-01-31 · 在第 27 页
- High-dimensional, outcome-dependent missing data problems: Models for the human KIR loci · SMMR · 2025-01-31 · 在第 27 页
- Semiparametric estimator for the covariate-specific receiver operating characteristic curve · SMMR · 2025-01-23 · 在第 28 页
- Multicategory matched learning for estimating optimal individualized treatment rules in observational studies with application to a hepatocellular carcinoma study · SMMR · 2025-01-23 · 在第 28 页
- The effect of estimating prevalences on the population-wise error rate · SMMR · 2025-01-19 · 在第 28 页
- Group sequential design using restricted mean survival time as the primary endpoint in clinical trials · SMMR · 2025-01-19 · 在第 28 页
- Estimating target population treatment effects in meta-analysis with individual participant-level data · SMMR · 2025-01-19 · 在第 28 页
- Efficient estimation of the marginal mean of recurrent events in randomized controlled trials · SMMR · 2025-01-19 · 在第 28 页
- A contaminated regression model for count health data · SMMR · 2025-01-19 · 在第 28 页
- Adjusting for switches to multiple treatments: Should switches be handled separately or combined? · SMMR · 2025-01-17 · 在第 28 页
- Using circulating tumor DNA as a novel biomarker of efficacy for dose-finding designs in oncology · SMMR · 2025 · 在第 29 页
- Competing risks models with two time scales · SMMR · 2025 · 在第 36 页